Synthesis, characterization, antitubercular and antibacterial activity, and molecular docking of 2,3-disubstituted quinazolinone derivatives

References

• Butler MS, Blaskovich MA, Cooper MA. Antibiotics in the clinical pipeline in 2013. J Antibiot. 2013;66:571-591.
   PubMed Web of Science ®Google Scholar
• WHO. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014. Available form: http://www.who.int/tb/publications/global_report/en/. Accessed June 5, 2015.
   Google Scholar
• Büyüktimkin S. Synthesis, pharmacology and structure-activity relationships of 2-methyl-3-(4-oxo-3-phenyl-thiazolidin-2-ylidenamino)-4(H)-quinazolinone derivatives. Arch Pharm. 1985;318:496–501.
   Web of Science ®Google Scholar
• Büyüktimkin S, Büyüktimkin N, Özdemir O, Rollas S. Synthesis of 3-[2-(2,3-dihydro-5-phenyl-4-substituted-3H-1,2,4-triazole-3-thione-2-yl)-acetylamino]-2-methyl-4(3H)-quinazolinones and their pharmacological activities. Arch Pharm. 1989;322:49–52.
   Web of Science ®Google Scholar
• Mukherji DD, Nintiyal SR, Prasad CR, Dhawan BN. Pharmacological studies on quinazolinones. Ind J Med Res. 1980;93:1426–1432.
   Google Scholar
• Peet NP, Baugh LE, Sunder S, et al. 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new anti-allergic agent. J Med Chem. 1986;29:2403–2409.
   PubMed Web of Science ®Google Scholar
• Chaurasia MR, Sharma SK. Synthesis of some new 4(3H)-quinazolinones as a potent CNS depressant. Arch Pharm. 1982;315:377–381.
   PubMed Web of Science ®Google Scholar
• Li H, Wang JP, Yang F, et al. Design, synthesis and biological activity evaluation of 2-mercapto-4(3H) quinazolinone derivatives as a novel inhibitor of protein tyrosine phosphatase 1B. Heterocycles. 2012;85:1897–1911.
   Web of Science ®Google Scholar
• Chiou WF, Liao JF, Chen CF. Comparative study on the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Nat Prod. 1996;59:374–378.
   Web of Science ®Google Scholar
• Nagase T, Mizutani T, Ishikawa S, et al. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists. J Med Chem. 2008;51:4780–4789.
   PubMed Web of Science ®Google Scholar
• Nanthakumar R, Muthumani P, Girija K. Anti-inflammatory and antibacterial activity study of some novel quinazolinones. Arabian J Chem. 2014;7:1049–1054.
   Web of Science ®Google Scholar
• Khodarahmi GA, Khajouel MR, Hakimelahi GH, Abedi D, Jafari E, Hassanzadeh F. Antibacterial, antifungal and cytotoxic evaluation of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives. Res Pharm Sci. 2012;7:151–158.
   PubMedGoogle Scholar
• Hemalatha K, Girija K. Synthesis, characterization, preliminary QSAR studies and in vitro antioxidant activity of some novel 2,3-disubstituted quinazolinone derivatives. Int J Pharm Sci. 2012;4:99–103.
   Google Scholar
• Panwar H, Chaudhary N, Singh S, Singh SH. Anti-inflammatory and antimicrobial activity of some new quinazolinones. Rasayan J Chem. 2011;4:498–505.
   Google Scholar
• Subramaniam R, Rao G, Jaiswal PK. Synthesis of some 2,3-disubstituted quinazolinone derivatives as antitubercular and antibacterial activity. Der Pharmacia sinica. 2014;5:37–40.
   Google Scholar
• Rozwarski D, Vilcheze C, Sugantino M, Bittman R, Sacchettini J. Crystal structure of the mycobacterium tuberculosis Enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate. J Biol Chem. 1999;274(22):15582–15589.
   PubMed Web of Science ®Google Scholar
• Franzblau SG, Witzig RS, Mclaughlin GC, et al. Rapid, low-technology MIC determination with clinical M. tuberculosis isolates by using the microplate Alamar blue assay. J Clin Microbiol. 1998;36:362–366.
   PubMed Web of Science ®Google Scholar
• Hanlon A, Taylor M, Dick JD. Agar dilution susceptibility testing. In: Schwalbe R, Moore LS, Goodwin AC, editors. Antimicrobial Susceptibility Testing Protocols. Volume 1. Boca Raton: CRC Press, Taylor and Francis group; 2007:91–104.
   Google Scholar
• Garcia LS, Isenberg HD. Clinical Microbiology Procedures Handbook. Volume 3. Washington DC: ASM Press; 2010.
   Google Scholar
• He X, Alian A, Stroud R, Montellano P. Pyrrolidine carboxamide as a novel class of inhibitors of enoyl acyl carrier protein reductase from M. tuberculosis. J Med Chem. 2006;49:6308–6323.
   PubMed Web of Science ®Google Scholar
• Pettersen E, Goddard T, Huang C, et al. UCSF chimera – a visualization system for exploratory research and analysis. J Comput Chem. 2004;13:1605–1612.
   Web of Science ®Google Scholar
• Dallakyan S, Olson A. Small molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243–250.
   PubMedGoogle Scholar
• Cambridgesoft corporation, a subsidiary of PerkinElmer, Inc. 2014. ChemBioDraw Ultra version 14.0.0.117 for Mac. Available from: www.cambridgesoft.com.
   Google Scholar
• The PyMOL molecular graphics system, version 1.7.4 Schrodinger, LLC. Available from: www.schrodinger.com/pymol/.
   Google Scholar
• Trott O, Olson A. Autodock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–461.
   PubMed Web of Science ®Google Scholar
• Kawadkar RK, Ghiya BJ. Synthesis of new quinazolin-4-one compounds of medicinal importance. Asian J Chem. 1999;11(2):388–391.
   Google Scholar
• Babu RR, Naresh K, Ravi A, Reddy BM, Babu VH. Synthesis of novel isoniazid incorporated styryl quinazolinones as anti-tubercular agents against isoniazid sensitive and MDR M. tuberculosis strains. Med Chem Res. 2014;23(10):4414–4419.
   Web of Science ®Google Scholar
• Nezhad AK, Haghighi, SM, Purkhosrow A, Panahi F. An efficient one-pot access to quinazolinone derivatives using TiO2 nanoparticles as catalyst: synthesis and vasorelaxant activity evaluation. Synlett. 2012;23(6):920–924.
   Google Scholar
• Wilczkiewicz AM, Kalinowski DS, Musiol R, Finster J, Szurko A, Serafin K. Investigating the anti-proliferative activity of styrylazanaphthalenes and azanaphthalenediones. Bioorg Med Chem. 2010;18:2664–2671.
   Web of Science ®Google Scholar
• Babu YR, Bhagavanraju M, Reddy GD, Peters GJ, Prasad VV. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase. Arch Pharm (Weinheim). 2014;347(9):624–634.
   PubMed Web of Science ®Google Scholar
• Hemalatha K, Kumar MS, Girija K. Dihydrofolate reductase inhibitors: synthesis, characterization and biological evaluation of some novel 2,3-disubstituted quinazolinones. Indian J Heterocycl Chem. 2014;24(1):35–40.
   Web of Science ®Google Scholar
• Srivastava VK, Palit G, Agarwal AK, Shanker K. Antiparkinsonian activity and behavioural effects of newer quinazolinones. Pharmacol Res Commun. 1987:19(9):617–628.
   Google Scholar
• Hemalatha K, Girija K. Synthesis of some novel 2,3-disubstituted quinazolinone derivatives as analgesic and anti-inflammatory agents. Int J Pharm Pharm Sci. 2011;3(2):103–106.
   Google Scholar
• Lovell S, Davis I, Arendall III W, et al. Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins. 2002;50:437–450.
   Web of Science ®Google Scholar
• Structural Analysis, Verification Server; 2011. Available from: http://nihserver.mbi.ucla.edu/SAVES/.
   Google Scholar